Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Sigilon Therapeutics Announces Pricing of Upsized Initial Public Offering

Sigilon Therapeutics 12.03.2020

Sigilon Therapeutics Receives Orphan Drug Designation for SIG-001 for the Treatment of Hemophilia A

Sigilon Therapeutics 08.27.2019

Sigilon Therapeutics Hires Glenn Reicin, Veteran Banking and Finance Strategist, as CFO

Sigilon Therapeutics 06.03.2019

Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued

Sigilon Therapeutics 01.30.2019

Sigilon Therapeutics and MIT Announce Research Collaboration to Advance Programmable Living Therapeutics for Serious Chronic Diseases

Sigilon Therapeutics 01.07.2019

Sigilon Therapeutics Announces Appointment of Four New Members of Senior Management Team

Sigilon Therapeutics 11.13.2018

Loading Animation
Loading
Process Companies
Preemptive Health & Medicine Pioneering Intelligence Pioneering Medicines Flagship Fellowship
Content People About Join Us Contact Careers Press